SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Ukraine
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Medicine of Ukraine (Ліки України (Чернігів))

Main Activities: Pharmacies and Drug Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Medicine of Ukraine (Ліки України, Чернігівське Обласне Кп)

Legal Address
vul. Shchorsa, 55; Chernihiv; Chernihiv Oblast; 14017
Status: Non-Listed
Legal Form: Other non-liability limited
Operational Status: Operational
EGRPOU: UA-01980762
Incorporation Date: April 15, 1998
Total Employees: 306

Tel: +38/0462/152224, +38/0462/675143, +38/0462/164616

Company Description

"Medicine of Ukraine" is one of the largest and most powerful pharmaceutical companies. It cooperates with retail companies, bringing them on a professional basis and acting as regional organizational methods of pharmaceutical center.
One of the main directions of the company is filling up pharmacy network with necessary assortment of drugs and medical devices.

Company Analysis

According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues increased with 7.02%, from UAH 194,183 thousands to UAH 207,813 thousands. Operating result decreased from UAH 1,795 thousands to UAH 1,783 thousands which means -0.67% change. The results of the period decreased -0.52% reaching UAH 950 thousands at the end of the period against UAH 955 thousands last year. Return on equity (Net income/Total equity) went from 6.68% to 6.34%, the Return On Asset (Net income / Total Asset) went from 2.71% to 2.51% and the Net Profit Margin (Net Income/Net Sales) went from 0.49% to 0.46% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 153.18% compared to 145.93% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.26 to 1.22 when compared to the previous year.

Key Executives

Svitlana Pastalytsia Director General
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
2011 Y
(non-cons)
2010 Y
(non-cons)
Audited Audited
Unit Thousands Thousands
Balance Sheet

Total Assets

37,909

35,175

Current Assets

XX,XXX

XX,XXX

Total Liabilities

XX,XXX

XX,XXX

Shareholders Equity

XX,XXX

XX,XXX

Current Liabilities

XX,XXX

XX,XXX

* All the accounts are in UAH.
Income Statement

Total Operating Revenue

XXX,XXX

XXX,XXX

Operational Profit (Loss)

X,XXX

X,XXX

Net Profit (Loss)

XXX

XXX

* All the accounts are in UAH.
Ratios
Profitability Ratios

Return on Assets (ROA)

X.XX%

X.XX%

Annualised Return on Assets (ROA)

X.XX%

X.XX%

Return on Equity (ROE)

X.XX%

X.XX%

Annualised Return on Equity (ROE)

X.XX%

X.XX%

Return on Sales (ROS)

X.XX%

X.XX%

Return on Capital

X.XX%

X.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

X.XX%

X.XX%

Efficiency Ratios

Accounts Receivable Turnover

XXX.XXx

X,XXX.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

XX.XXx

XX.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

X,XXX

X,XXX

EBITDA

X,XXX

X,XXX

Bookvalue (BV)

XX,XXX

XX,XXX

Net Cash

-XX,XXX

-XX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XX.XX%

X.XX%

Doom's day ratio

X.XX%

X.XX%

Cash Flow to Debt

X.XX%

X.X%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Interest Coverage Ratio

X,XXX.XX%

XXX.XX%

Debt to equity

XXX.XX%

XXX.XX%

Debt to total assets

XX.X%

XX.XX%

Long Term Debt to Capital

X.XX%

X.X%

Trend Ratios

Revenue Trend

XXX.XX%

Net Income Trend

XX.XX%

Operating Income Trend

XX.XX%